雜志介紹

Arthritis Research & Therapy雜志介紹

《Arthritis Research & Therapy》是一本以English為主的開放獲取國際優秀期刊，中文名稱關節炎研究與治療，本刊主要出版、報道醫學-RHEUMATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.4，最新CiteScore 指數為8.3。

本刊近期中國學者發表的論文主要有：

• Glutathione peroxidase 3 is a novel clinical diagnostic biomarker and potential therapeutic target for neutrophils in rheumatoid arthritis

  Author: Chen, Tao; Zhou, Zhen; Peng, Minge; Hu, Huifang; Sun, Rui; Xu, Jiayi; Zhu, Chenxi; Li, Yanhong; Zhang, Qiuping; Luo, Yubin; Yang, Bin; Dai, Lunzhi; Liu, Yi; Munoz, Luis E.; Meng, Liesu; Herrmann, Martin; Zhao, Yi

• Potential effects of teriparatide (PTH (1-34)) on osteoarthritis: a systematic review

  Author: Li, Guoqing; Liu, Su; Xu, Huihui; Chen, Yixiao; Deng, Jiapeng; Xiong, Ao; Wang, Deli; Weng, Jian; Yu, Fei; Gao, Liang; Ding, Changhai; Zeng, Hui

• Differential CpG DNA methylation of peripheral B cells, CD4(+) T cells, and salivary gland tissues in IgG4-related disease

  Author: Wu, Xunyao; Wang, Anqi; Wang, Mu; Peng, Yu; Chen, Yingying; Li, Jieqiong; Liu, Zheng; Lu, Hui; Zhou, Jiaxin; Peng, Linyi; Zhao, Yan; Zeng, Xiaofeng; Fei, Yunyun; Zhang, Wen

• Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis

  Author: Liao, Hua; Zhang, Nan; Pan, Lili; Du, Juan; Liu, Jiayi; Zheng, Yi

英文介紹

Arthritis Research & Therapy雜志英文介紹

Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.

A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.

Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.